Adaptive Biotechnologies【ADPT】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

6.12

買値

6.11

売値

6.12

出来高

196,736

5.91 日の範囲 6.16

2.28 52 週間の範囲 7.0665

時価総額

903.186M

前日終値

6.29

始値

6.16

時刻

6.116

最終取引時間

02:30:11

財務取引量

US$ 1,194,118

VWAP

6.0696

平均取引量 (3 か月)

1,154,909

発行済株式数

147,579,486

配当利回り

PER

-4.00

1 株当たり利益 (EPS)

-1.53

歳入

170.28M

純利益

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.adaptivebiotech.com

本社

Olympia, Washington, USA

設立

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker ADPT. The last closing price for Adaptive Biotechnologies was US$6.29. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of US$ 2.28 to US$ 7.0665.

Adaptive Biotechnologies currently has 147,579,486 shares in issue. The market capitalisation of Adaptive Biotechnologies is US$928.27 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -4.00.

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies show depth of response at 10-6 provides more accurate assessment...

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate...

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.25	-3.92464678179	6.37	6.52	5.91	622310	6.35470583	CS
4	0.1	1.66112956811	6.02	7.0665	5.805	1100512	6.34742623	CS
12	0.61	11.0707803993	5.51	7.0665	4.27	1154909	5.53725087	CS
26	2.42	65.4054054054	3.7	7.0665	3.3	1190038	4.92768021	CS
52	1.18	23.8866396761	4.94	7.0665	2.28	1388070	4.0908623	CS
156	-20.1669	-76.7184415051	26.2869	29.17	2.28	1295760	6.94587617	CS
260	-23.06	-79.0267306374	29.18	71.25	2.28	1142170	17.42248162	CS

ADPT - Frequently Asked Questions (FAQ)

What is the current Adaptive Biotechnologies share price?

The current share price of Adaptive Biotechnologies is US$ 6.12

How many Adaptive Biotechnologies shares are in issue?

Adaptive Biotechnologies has 147,579,486 shares in issue

What is the market cap of Adaptive Biotechnologies?

The market capitalisation of Adaptive Biotechnologies is USD 928.27M

What is the 1 year trading range for Adaptive Biotechnologies share price?

Adaptive Biotechnologies has traded in the range of US$ 2.28 to US$ 7.0665 during the past year

What is the PE ratio of Adaptive Biotechnologies?

The price to earnings ratio of Adaptive Biotechnologies is -4

What is the cash to sales ratio of Adaptive Biotechnologies?

The cash to sales ratio of Adaptive Biotechnologies is 5.3

What is the reporting currency for Adaptive Biotechnologies?

Adaptive Biotechnologies reports financial results in USD

What is the latest annual turnover for Adaptive Biotechnologies?

The latest annual turnover of Adaptive Biotechnologies is USD 170.28M

What is the latest annual profit for Adaptive Biotechnologies?

The latest annual profit of Adaptive Biotechnologies is USD -225.25M

What is the registered address of Adaptive Biotechnologies?

The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267

What is the Adaptive Biotechnologies website address?

The website address for Adaptive Biotechnologies is www.adaptivebiotech.com

Which industry sector does Adaptive Biotechnologies operate in?

Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
NXUNXU Inc	US$ 2.05 (742.24%)	454.64M
WATTEnergous Corporation	US$ 1.4514 (252.97%)	167.21M
INTZIntrusion Inc	US$ 5.522 (155.65%)	116.05M
JDZGJIADE Ltd	US$ 1.43 (104.23%)	5.75M
CYNCYNGN Inc	US$ 1.17 (86.34%)	61.57M
ABPAbpro Holdings Inc	US$ 2.1874 (-51.28%)	1.47M
TRAWTraws Pharma Inc	US$ 7.60 (-43.37%)	905.47k
SHOTWSafety Shot Inc	US$ 0.122005 (-32.33%)	1.1k
LITMSnow Lake Resources Ltd	US$ 1.125 (-29.69%)	45.23M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	US$ 66.74 (-24.56%)	8.99k
NXUNXU Inc	US$ 2.05 (742.24%)	454.64M
VINCVincerx Inc	US$ 0.332999 (71.65%)	303.66M
XTIAXTI Aerospace Inc	US$ 0.0399 (1.01%)	186.41M
WATTEnergous Corporation	US$ 1.4514 (252.97%)	167.21M
SMXSMX Security Matters Public Company	US$ 0.6088 (72.17%)	140.78M